Clinical Medicine
Listando 35 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions
73
Twitter
0
Wikipedia
37
News
0
Policy
Article
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
Nuciforo, P.; Pascual, T.; Cortes, J.; Llombart-Cussac, A.; Fasani, R.; Pare, L.; Oliveira, M.; Galvan, P.; Martinez, N.; Bermejo, B.; Vidal, M.; Pernas, S.; Lopez, R.; Munoz, M.; Garau, I.; Manso, L.; Alarcon, J.; Martinez, E.; Rodrik-Outmezguine, V.; Bra
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdx647
Bronze
Mentions
193
Twitter
0
Wikipedia
9
News
0
Policy
Article
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Prat, Aleix; Saura, Cristina; Pascual, Tomas; Hernando, Cristina; Munoz, Montserrat; Pare, Laia; Gonzalez Farre, Blanca; Fernandez, Pedro L.; Galvan, Patricia; Chic, Nuria; Gonzalez Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Arumi, Miriam; Ferrer,
LANCET ONCOLOGY
1470-2045 (2020)
DOI /
10.1016/s1470-2045(19)30786-7
Mentions
192
Twitter
0
Wikipedia
9
News
0
Policy
Article
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Schettini, Francesco; Chic, Nuria; Braso-Maristany, Fara; Pare, Laia; Pascual, Tomas; Conte, Benedetta; Martinez-Saez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernandez-Martinez, Aranzazu; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Ju
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-020-00208-2
Green published, Gold
Mentions
231
Twitter
0
Wikipedia
0
News
0
Policy
Article
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Ciruelos, Eva; Villagrasa, Patricia; Pascual, Tomas; Oliveira, Mafalda; Pernas, Sonia; Pare, Laia; Escriva-de-Romani, Santiago; Manso, Luis; Adamo, Barbara; Martinez, Eduardo; Cortes, Javier; Vazquez, Silvia; Perello, Antonia; Garau, Isabel; Mele, Mireia;
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-0844
Mentions
50
Twitter
0
Wikipedia
5
News
0
Policy
Article
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
Prat, Aleix; Pascual, Tomas; De Angelis, Carmine; Gutierrez, Carolina; Llombart-Cussac, Antonio; Wang, Tao; Cortes, Javier; Rexer, Brent; Pare, Laia; Forero, Andres; Wolff, Antonio C.; Morales, Serafin; Adamo, Barbara; Braso-Maristany, Fara; Vidal, Maria;
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
0027-8874 (2020)
DOI /
10.1093/jnci/djz042
Green published, Bronze
Mentions
125
Twitter
0
Wikipedia
0
News
0
Policy
Article
Gene expression profiles of breast cancer metastasis according to organ site
Braso-Maristany, Fara; Pare, Laia; Chic, Nuria; Martinez-Saez, Olga; Pascual, Tomas; Mallafre-Larrosa, Meritxell; Schettini, Francesco; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Martinez, Debora; Galvan, Patricia; Barnadas, Esther; Salinas, Belinda; Tolosa
MOLECULAR ONCOLOGY
1574-7891 (2021)
DOI /
10.1002/1878-0261.13021
Gold DOAJ
Mentions
73
Twitter
0
Wikipedia
2
News
0
Policy
Article
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Prat, Aleix; Navarro, Alejandro; Pare, Laia; Reguart, Noemi; Galvan, Patricia; Pascual, Tomas; Martinez, Alex; Nuciforo, Paolo; Comerma, Laura; Alos, Llucia; Pardo, Nuria; Cedres, Susana; Fan, Cheng; Parker, Joel S.; Gaba, Lydia; Victoria, Ivan; Vinolas, N
CANCER RESEARCH
0008-5472 (2017)
DOI /
10.1158/0008-5472.can-16-3556
Bronze
Mentions
55
Twitter
0
Wikipedia
2
News
0
Policy
Article
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Pare, L.; Pascual, T.; Segui, E.; Teixido, C.; Gonzalez-Cao, M.; Galvan, P.; Rodriguez, A.; Gonzalez, B.; Cuatrecasas, M.; Pineda, E.; Torne, A.; Crespo, G.; Martin-Algarra, S.; Perez-Ruiz, E.; Reig, O.; Viladot, M.; Font, C.; Adamo, B.; Vidal, M.; Gaba, L
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdy335
Bronze
Mentions
109
Twitter
0
Wikipedia
0
News
0
Policy
Article
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy
Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara; Vidal, Maria; Martinez, Debora; Galvan, Patricia; Gonzalez-Farre, Blanca; Cortes, Javier; Gavila, Joaquin; Saura, Cristina; Oliveira, Mafalda; Pernas, Sonia; Martin
EBIOMEDICINE
2352-3964 (2021)
DOI /
10.1016/j.ebiom.2021.103451
Green published, Gold
Mentions
85
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Braso-Maristany, Fara; Griguolo, Gaia; Pascual, Tomas; Pare, Laia; Nuciforo, Paolo; Llombart-Cussac, Antonio; Bermejo, Begona; Oliveira, Mafalda; Morales, Serafin; Martinez, Noelia; Vidal, Maria; Adamo, Barbara; Martinez, Olga; Pernas, Sonia; Lopez, Rafael
NATURE COMMUNICATIONS
(2020)
DOI /
10.1038/s41467-019-14111-3
Gold DOAJ, Green published
Mentions
81
Twitter
0
Wikipedia
0
News
0
Policy
Article
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
Martinez-Saez, Olga; Pascual, Tomas; Braso-Maristany, Fara; Chic, Nuria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Anna Belen; Schettini, Francesco; Conte, Benedetta; Vidal, Maria; Adamo, Bar
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00218-8
Gold DOAJ, Green published
Mentions
50
Twitter
0
Wikipedia
1
News
0
Policy
Review
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
Schettini, Francesco; Pascual, Tomas; Conte, Benedetta; Chic, Nuria; Braso-Maristany, Fara; Galvan, Patricia; Martinez, Olga; Adamo, Barbara; Vidal, Maria; Munoz, Montserrat; Fernandez-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina
CANCER TREATMENT REVIEWS
0305-7372 (2020)
DOI /
10.1016/j.ctrv.2020.101965
Mentions
73
Twitter
0
Wikipedia
1
News
0
Policy
Article
A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor-positive HER2-negative Breast Cancer
Prat, Aleix; Tsai, Yi-Hsuan; Pascual, Tomas; Pare, Laia; Adamo, Barbara; Vidal, Maria; Braso-Maristany, Fara; Galvan, Patricia; Brase, Jan Christoph; Rodrik-Outmezguine, Vanessa; Johnston, Stephen; Ciruelos, Eva; Parker, Joel S.
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-2793
Mentions
87
Twitter
0
Wikipedia
0
News
0
Policy
Article
ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria; Sauri, Tamara; Kates, Ronald; Gluz, Oleg; Martinez, Debora; Pare, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Galv
CANCERS
(2020)
DOI /
10.3390/cancers12071902
Gold DOAJ, Green published
Mentions
64
Twitter
0
Wikipedia
0
News
0
Policy
Article
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Martinez-Saez, Olga; Chic, Nuria; Pascual, Tomas; Adamo, Barbara; Vidal, Maria; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Braso-Maristany, Fara; Rodriguez, Adela; Martinez, Debora; Galvan, Patricia; Rodriguez, Ana Be
BREAST CANCER RESEARCH
1465-542X (2020)
DOI /
10.1186/s13058-020-01284-9
Gold DOAJ, Green published
Mentions
49
Twitter
0
Wikipedia
0
News
0
Policy
Article
Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis
Pascual, Tomas; Gonzalez-Farre, Blanca; Teixido, Cristina; Oleaga, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Nuria; Riu, Gisela; Adamo, Barbara; Galvan, Patricia; Vidal, Maria; Soy, Dolors; Urbano, Alvaro; Munoz, Monserrat; Prat, Aleix
JCO PRECISION ONCOLOGY
(2019)
DOI /
10.1200/po.19.00012
Mentions
55
Twitter
0
Wikipedia
0
News
0
Policy
Article
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial
Adamo, Barbara; Bellet, Meritxell; Pare, Laia; Pascual, Tomas; Vidal, Maria; Perez Fidalgo, Jose A.; Blanch, Salvador; Martinez, Noelia; Murillo, Laura; Gomez-Pardo, Patricia; Lopez-Gonzalez, Ana; Amillano, Kepa; Canes, Jordi; Galvan, Patricia; Gonzalez-Fa
BREAST CANCER RESEARCH
1465-542X (2019)
DOI /
10.1186/s13058-019-1195-z
Gold DOAJ, Green published
Mentions
46
Twitter
0
Wikipedia
0
News
0
Policy
Review
Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer
Miguel Cejalvo, Juan; Pascual, Tomas; Fernandez-Martinez, Aranzazu; Braso-Maristany, Fara; Gomis, Roger R.; Perou, Charles M.; Munoz, Montserrat; Prat, Aleix
CANCER TREATMENT REVIEWS
0305-7372 (2018)
DOI /
10.1016/j.ctrv.2018.04.015
Gold other
Mentions
61
Twitter
0
Wikipedia
0
News
0
Policy
Article
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
Pascual, Tomas; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavila, Joaquin; Pernas, Sonia; Munoz, Montserrat; Vidal, Maria J.; Margeli Vila, Mireia; Cejalvo, Juan M.; Gonzalez-Farre, Blanca; Espinosa-Bravo, Martin; Cruz,
FRONTIERS IN ONCOLOGY
2234-943X (2021)
DOI /
10.3389/fonc.2021.638482
Gold DOAJ, Green published
Mentions
46
Twitter
0
Wikipedia
0
News
0
Policy
Review
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer
Griguolo, Gaia; Pascual, Tomas; Dieci, Maria Vittoria; Guarneri, Valentina; Prat, Aleix
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2019)
DOI /
10.1186/s40425-019-0548-6
Gold DOAJ, Green published
Mentions
47
Twitter
0
Wikipedia
0
News
0
Policy
Article
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer
Pascual, Tomas; Cejalvo, Juan M.; Oliveira, Mafalda; Vidal, Maria; Vega, Estela; Ganau, Sergi; Julve, Ana; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begona; de la Cruz-Merino, Luis; Juan, Manel; Ferrero-Cafiero, Juan M.; Canes, Jordi; Gonzal
FUTURE ONCOLOGY
1479-6694 (2020)
DOI /
10.2217/fon-2020-0246
Mentions
51
Twitter
0
Wikipedia
0
News
0
Policy
Article
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy
Pascual, Tomas; Fernandez-Martinez, Aranzazu; Tanioka, Maki; Dieci, M. Vittoria; Pernas, Sonia; Gavila, Joaquin; Guarnieri, Valentina; Cortes, Javier; Villagrasa, Patricia; Chic, Nuria; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Griguolo, Gaia; Llomb
CLINICAL CANCER RESEARCH
1078-0432 (2021)
DOI /
10.1158/1078-0432.ccr-20-4102
Bronze
Mentions
39
Twitter
0
Wikipedia
0
News
0
Policy
Article
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
Gavila, Joaquin; Oliveira, Mafalda; Pascual, Tomas; Perez-Garcia, Jose; Gonzalez, Xavier; Canes, Jordi; Pare, Laia; Calvo, Isabel; Ciruelos, Eva; Munoz, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andres, Raquel; Perello, Antonia; Martinez, Jeronimo; Mor
BMC MEDICINE
1741-7015 (2019)
DOI /
10.1186/s12916-018-1233-1
Green published, Gold
Mentions
41
Twitter
0
Wikipedia
0
News
0
Policy
Article
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial
Pascual, Tomas; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Pare, Laia; Bermejo, Begona; Morales, Serafin; Amillano, Kepa; Lopez, Rafael; Galvan, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T.; Llombart-Cussac, A
NPJ BREAST CANCER
(2021)
DOI /
10.1038/s41523-021-00351-4
Gold
Mentions
44
Twitter
0
Wikipedia
0
News
0
Policy
Article
A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer
Pascual, Tomas; Martin, Miguel; Fernandez-Martinez, Aranzazu; Pare, Laia; Alba, Emilio; Rodriguez-Lescure, Alvaro; Perrone, Giuseppe; Cortes, Javier; Morales, Serafin; Lluch, Ana; Urruticoechea, Ander; Gonzalez-Farre, Blanca; Galvan, Patricia; Jares, Pedro
FRONTIERS IN ONCOLOGY
2234-943X (2019)
DOI /
10.3389/fonc.2019.00303
Gold DOAJ, Green published
Mentions
36
Twitter
0
Wikipedia
0
News
0
Policy
Article
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
Griguolo, G.; Serna, G.; Pascual, T.; Fasani, R.; Guardia, X.; Chic, N.; Pare, L.; Pernas, S.; Munoz, M.; Oliveira, M.; Vidal, M.; Llombart-Cussac, A.; Cortes, J.; Galvan, P.; Bermejo, B.; Martinez, N.; Lopez, R.; Morales, S.; Garau, I; Manso, L.; Alarcon,
NPJ PRECISION ONCOLOGY
(2021)
DOI /
10.1038/s41698-021-00163-6
Gold DOAJ
Mentions
31
Twitter
0
Wikipedia
0
News
0
Policy
Article
De-escalated therapy for HR+/HER2+breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Guarneri, V; Dieci, M., V; Bisagni, G.; Frassoldati, A.; Bianchi, G., V; De Salvo, G. L.; Orvieto, E.; Urso, L.; Pascual, T.; Pare, L.; Galvan, P.; Ambroggi, M.; Giorgi, C. A.; Moretti, G.; Griguolo, G.; Vicini, R.; Prat, A.; Conte, P. F.
ANNALS OF ONCOLOGY
0923-7534 (2019)
DOI /
10.1093/annonc/mdz055
Gold other, Green published
Mentions
25
Twitter
0
Wikipedia
0
News
0
Policy
Article
Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2
Prat, Aleix; Christoph Brase, Jan; Cheng, Yuan; Nuciforo, Paolo; Pare, Laia; Pascual, Tomas; Martinez, Debora; Galvan, Patricia; Vidal, Maria; Adamo, Barbara; Hortobagyi, Gabriel N.; Baselga, Jose; Ciruelos, Eva
ONCOLOGIST
1083-7159 (2019)
DOI /
10.1634/theoncologist.2018-0407
Green published, Bronze
Mentions
19
Twitter
0
Wikipedia
0
News
0
Policy
Article
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data
Diaz-Redondo, Tamara; Lavado-Valenzuela, Rocio; Jimenez, Begona; Pascual, Tomas; Galvez, Fernando; Falcon, Alejandro; Alamo, Maria del Carmen; Morales, Cristina; Amerigo, Marta; Pascual, Javier; Sanchez-Munoz, Alfonso; Gonzalez-Guerrero, Macarena; Vicioso,
FRONTIERS IN ONCOLOGY
2234-943X (2019)
DOI /
10.3389/fonc.2019.01178
Gold DOAJ, Green published
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer
Sanz-Moreno, Adrian; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomas; Galvan, Patricia; Benitez, Sandra; Gomez-Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sonia; Petit, Anna; Soler-Monso, Maria Teresa; Vinas, Gemma; Alsaleem
BREAST CANCER RESEARCH
1465-542X (2021)
DOI /
10.1186/s13058-021-01390-2
Green published, Gold
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer
Pascual, Tomas; Apellaniz-Ruiz, Maria; Pernaut, Cristina; Cueto-Felgueroso, Cecilia; Villalba, Pablo; Alvarez, Carlos; Manso, Luis; Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina; Ciruelos, Eva
PLOS ONE
1932-6203 (2017)
DOI /
10.1371/journal.pone.0180192
Green submitted, Gold, Green published
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
Ciruelos, Eva M.; Montano, Alvaro; Rodriguez, Cesar A.; Gonzalez-Flores, Encarnacion; Lluch, Ana; Garrigos, Laia; Quiroga, Vanesa; Anton, Antonio; Malon, Diego; Chacon, Jose, I; Velasco, Montserrat; Gonzalez-Cortijo, Lucia; Jolis, Laura; Echarri, Maria J.;
EUROPEAN JOURNAL OF CANCER CARE
0961-5423 (2020)
DOI /
10.1111/ecc.13253
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement
Colomer, Ramon; Saura, Cristina; Sanchez-Rovira, Pedro; Pascual, Tomas; Rubio, Isabel T.; Burgues, Octavio; Marcos, Lourdes; Rodriguez, Cesar A.; Martin, Miguel; Lluch, Ana
ONCOLOGIST
1083-7159 (2019)
DOI /
10.1634/theoncologist.2018-0228
Green published, Bronze
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Ne
Ciruelos, Eva; Apellaniz-Ruiz, Maria; Cantos, Blanca; Martinez-Janez, Noelia; Bueno-Muino, Coralia; Echarri, Maria-Jose; Enrech, Santos; Guerra, Juan-Antonio; Manso, Luis; Pascual, Tomas; Dominguez, Cristina; Gonzalo, Juan-Francisco; Sanz, Juan-Luis; Rodri
ONCOLOGIST
1083-7159 (2019)
DOI /
10.1634/theoncologist.2017-0664
Green published, Bronze
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
Fernandez-Martinez, Aranzazu; Pascual, Tomas; Perrone, Giuseppe; Morales, Serafin; de la Haba, Juan; Gonzalez-Rivera, Milagros; Galvan, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucia; Prats, Miquel; Rojo, Federico; Manso, Luis; Pare, Laia; Alo
ONCOTARGET
1949-2553 (2017)
DOI /
10.18632/oncotarget.15748
Bronze, Green published
